United States · Bill · HR
H.R. 5350 (107th)
Prescription Affordability and Medicine Safety Act of 2002
Introduced
9 September 2002
Last action
23 September 2002 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Kennedy, Patrick J. [D-RI-1], Rep. Hilliard, Earl F. [D-AL-7], Rep. Lipinski, William O. [D-IL-3], Rep. Frost, Martin [D-TX-24], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Crowley, Joseph [D-NY-14], Rep. Allen, Thomas H. [D-ME-1], Sen. Sanders, Bernard [I-VT]
Subjects
Healthcare, Taxation, Education
Source updated
19 August 2025
Healthcare · Taxation · Education
Summary
Prescription Affordability and Medicine Safety Act of 2002 - Authorizes appropriations for the Food and Drug Administration (FDA) for generic drug application review and the continuation of the education program on the use and therapeutic equivalency of drugs. Amends the Public Health Service Act to authorize the Secretary of Health and Human Services to make grants to States in support of State pharmacy benefit assistance programs. Requires a percentage of profits from the sale of certain drugs and biological products to be placed in a revolving fund and used to support the grants program. Limits the tax deductions for advertizing for prescription drug manufacturers. Limits the extension of the 30 month stay of FDA approval for any new (generic) drug, as specified, thereby limiting the brand name drug's patent owner's period of exclusive sales. Makes a patent owner's failure to timely file a civil action for infringement a bar to later action. Sets forth requirements for filing drug patent information with the FDA. Makes a patent owner's failure to timely file with the FDA a bar to civil actions for patent infringement. Requires the first generic drug applicant with a specified certification to forfeit the 180 day marketing exclusivity period to a subsequent generic drug applicant if the first generic drug applicant engages in certain behaviors which delay or prevent the marketing of the generic drug.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 September 2002
Introduced
Introduced in House
Source: IntroReferral
9 September 2002
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
9 September 2002
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
9 September 2002
Introduced
Introduced in House
Source: IntroReferral
23 September 2002
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 9 September 2002 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 9 September 2002
Introduced in House (PDF)
Introduced in House · EN · 9 September 2002
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 9 September 2002
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Kennedy, Patrick J. [D-RI-1] · D · Sponsor
- Rep. Hilliard, Earl F. [D-AL-7] · D · Cosponsor
- Rep. Lipinski, William O. [D-IL-3] · D · Cosponsor
- Rep. Frost, Martin [D-TX-24] · D · Cosponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
- Rep. Crowley, Joseph [D-NY-14] · D · Cosponsor
- Rep. Allen, Thomas H. [D-ME-1] · D · Cosponsor
- Sen. Sanders, Bernard [I-VT] · I · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/house-bill/5350
- Open data entity: https://api.congress.gov/v3/bill/107/hr/5350
- us · 107-hr-5350 · source updated 19 August 2025